As per MRFR analysis, the US Ophthalmic Viscoelastic Devices Market Size was estimated at 700.7 (USD Million) in 2023. The US Ophthalmic Viscoelastic Devices Market Industry is expected to grow from 752.15(USD Million) in 2024 to 1,429.82 (USD Million) by 2035. The US Ophthalmic Viscoelastic Devices Market CAGR (growth rate) is expected to be around 6.014% during the forecast period (2025 - 2035).
The US Ophthalmic Viscoelastic Devices Market is witnessing significant trends driven by an increasing prevalence of eye conditions and a growing geriatric population. The demand for ophthalmic surgeries, particularly cataract and glaucoma procedures, is propelling the use of viscoelastic devices. Technological advancements in product offerings, like improved formulations and biodegradable options, are reshaping the market landscape, providing surgeons with better tools during eye surgeries.
Opportunities for growth are emerging as healthcare providers continue to invest in minimally invasive surgical techniques, which rely heavily on the use of these devices. With the rise in outpatient surgery centers, the accessibility and application of ophthalmic viscoelastic devices are expanding. Further investment in research and development is vital, as innovations can enhance safety and efficiency during procedures. Recent trends reflect an uptick in training and education programs for surgeons, emphasizing the optimal application of these devices in surgery.
Awareness campaigns about eye health, supported by various organizations, are also driving demand as more patients seek treatment for eye-related issues. Moreover, the influence of telehealth services in the US is transforming patient engagement, allowing for better pre-and post-operative care. The combination of these factors indicates a dynamic growth trajectory for the ophthalmic viscoelastic devices market, with a promising future as needs and technologies evolve in the US healthcare system.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Ophthalmic Viscoelastic Devices Market Industry is significantly driven by the increasing prevalence of eye disorders such as cataracts, glaucoma, and age-related macular degeneration. The Centers for Disease Control and Prevention (CDC) reported that approximately 24 million Americans aged 40 and older have cataracts, which is projected to escalate due to an aging population. The National Eye Institute estimates that by 2050, the number of people with cataracts will double to 50 million.
This rising incidence of eye disorders emphasizes the need for effective surgical interventions, ultimately increasing the demand for ophthalmic viscoelastic devices, which play a crucial role in maintaining eye pressure and stability during surgeries.
The US Ophthalmic Viscoelastic Devices Market Industry is experiencing growth due to continuous technological advancements in surgical procedures. Innovative devices such as viscoelastic solutions have been developed to enhance surgical outcomes and patient safety during ophthalmic surgeries. According to the American Academy of Ophthalmology, advancements in minimally invasive techniques and the introduction of new formulations of viscoelastic agents have significantly improved surgical precision and recovery times.
Major industry players are investing in Research and Development to create advanced viscoelastic devices, which is contributing to market expansion and improved patient care.
Government initiatives and funding for eye health and research are significantly bolstering the US Ophthalmic Viscoelastic Devices Market Industry. The National Eye Institute is investing millions each year into research and outreach programs aimed at preventing, diagnosing, and treating eye diseases. The US government's Healthy People 2030 initiative aims to reduce the burden of vision problems, highlighting the importance of eye care.
As a consequence of increased funding, there has been a rise in successful innovations in viscoelastic device technology, further driving market growth as these improvements lead to better surgical outcomes and reduce healthcare costs.
The US Ophthalmic Viscoelastic Devices Market Industry is also bolstered by increasing awareness of eye health and the accessibility of eye care services. As public health campaigns, such as those run by the American Optometric Association, promote regular eye examinations, there is a greater public understanding of various eye conditions and the necessity for surgery. According to a report from the National Health Interview Survey, approximately 50% of adults reported visiting an eye care professional in the past year, indicating a growing demand for surgical solutions.
This rising awareness has resulted in more individuals seeking intervention for eye conditions, thereby increasing the demand for ophthalmic viscoelastic devices in surgeries.
The US Ophthalmic Viscoelastic Devices Market is characterized by a significant focus on product types that enhance surgical outcomes in ophthalmic procedures. Within this market, the two primary types are Cohesive Ocular Viscoelastic Devices (OVDs) and Dispersive OVDs, each fulfilling distinct roles in surgical applications. Cohesive OVDs, known for their ability to maintain space within the eye during surgery, provide essential support for the delicate tissues, thus preventing complications.
Their properties allow for easy removal post-surgery, making them an invaluable asset in procedures such as cataract surgery, where visibility and space maintenance are crucial. Conversely, Dispersive OVDs are designed to protect and coat tissues while minimizing inflammation, playing a vital role in procedures where surgical stress on corneal endothelial cells is a concern.
These devices' unique characteristics enable them to create a barrier, facilitating the safe and effective execution of intricate surgical maneuvers. The adoption of these products is further driven by ongoing advancements and innovations within the ophthalmic industry, as they enhance performing capabilities in an array of conditions, including cataract and glaucoma surgeries. Factors such as the aging population in the US, which continues to see a rise in ocular diseases, alongside increasing awareness about the importance of surgical precision, have amplified the demand for these OVDs.
Overall, this Type segmentation allows stakeholders to cater to the specific needs of surgical environments, fostering better patient outcomes, thereby solidifying their significance in the US Ophthalmic Viscoelastic Devices Market landscape. By addressing the diverse roles that Cohesive and Dispersive OVDs play, the market presents opportunities for targeted product development and strategic investment, tailored to meet evolving needs in ophthalmic surgery.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Application segment of the US Ophthalmic Viscoelastic Devices Market encompasses crucial procedures, including Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, and Vitreoretinal Surgery, each playing a significant role in the overall market dynamics. Cataract surgery, which has seen a rise in prevalence due to an aging population, represents a major driver in the market, as these devices are essential for maintaining intraocular pressure and providing better visualization during the procedure.
Glaucoma surgery is also gaining traction, especially with the increase in incidences of this eye condition that affects millions in the US, highlighting the growing need for effective treatment options. Corneal transplantation is indispensable for patients with severe corneal issues, where viscoelastic devices ensure smooth surgical procedures by protecting delicate tissues. Lastly, vitreoretinal surgery, which addresses various retinal conditions, underscores the importance of high-quality viscoelastic materials in promoting successful surgical outcomes.
Collectively, these applications significantly contribute to the market growth, reflecting the shifting trends towards more advanced surgical solutions and an increasing demand for minimally invasive procedures. The continued focus on innovation in device design and material composition is critical in addressing the evolving requirements of these surgical applications within the US Ophthalmic Viscoelastic Devices Market.
The End User segment of the US Ophthalmic Viscoelastic Devices Market encompasses a broad spectrum of healthcare facilities including Ophthalmic Clinics and Phaco Centers, Hospitals, as well as Academic and Research Institutes. Ophthalmic Clinics and Phaco Centers are pivotal as they specialize in cataract surgeries and other ophthalmic procedures, thereby driving demand for viscoelastic devices that aid in maintaining eye shape during surgery.
Hospitals play a crucial role as they facilitate a wide array of surgical options, catering to both routine and complex ophthalmic interventions, which necessitates high-quality viscoelastic materials. Meanwhile, Academic and Research Institutes are significant for their contributions to innovation and development within the field; they not only conduct vital Research and Development but also train the next generation of ophthalmic professionals.
The increasing prevalence of eye diseases in the US is propelling advancements in surgical techniques, further solidifying the importance of these end user segments in shaping the Ophthalmic Viscoelastic Devices Market landscape. As the aging population continues to grow, the demand from these sectors is expected to expand, highlighting their essential role in improving patient outcomes and advancing surgical practices. Additionally, ongoing technological innovations are anticipated to enhance the effectiveness of viscoelastic devices, further supporting market growth across all segments.
The competitive landscape of the US Ophthalmic Viscoelastic Devices Market is characterized by significant growth opportunities driven by technological advancements and increasing demand for ocular surgeries. As a vital tool used in various ophthalmic surgical procedures, viscoelastic devices play a critical role in maintaining intraocular pressure and protecting intraocular tissues. This market is influenced by numerous factors including the diversity of product offerings, price competition, and the strategic initiatives of key players.
The market dynamics are shaped by ongoing innovations and regulatory approvals that aim to enhance product efficacy and safety. With shifts in consumer preferences and the rising incidence of eye disorders, companies are compelled to invest in research and development to maintain their competitive advantage. In the context of Genentech, the company has established a strong market presence in the US Ophthalmic Viscoelastic Devices Market through its commitment to innovation and patient-centric solutions. Known for its high-quality products and a robust pipeline, Genentech emphasizes the importance of research in developing advanced viscoelastic solutions that meet the evolving demands of ocular surgery.
The company's strengths lie in its extensive experience in biotechnology and a well-established distribution network, which enables it to penetrate various segments in the ophthalmic field effectively. Genentech's strategic collaborations and partnerships further bolster its competitive positioning, allowing for quicker market access and enhanced product visibility. Santen Pharmaceutical, on the other hand, has carved a niche in the US Ophthalmic Viscoelastic Devices Market with a focus on specialized ophthalmic treatments specifically designed for surgical and therapeutic use. The company’s key products cater to a variety of ocular procedures, enhancing surgical outcomes and patient safety.
Santen Pharmaceutical benefits from a strong emphasis on research and development, showcasing its commitment to innovation through continuous product improvements and new offerings. Its market presence is reinforced by significant mergers and acquisitions that not only expand its product portfolio but also enhance its operational capabilities within the US region. Through strategic alliances with healthcare providers and robust marketing initiatives, Santen Pharmaceutical aims to solidify its position and address unmet needs in the ophthalmic market.
Recent developments in the US Ophthalmic Viscoelastic Devices Market have shown a dynamic trend, particularly with companies like Genentech, Santen Pharmaceutical, and Alcon innovating their product offerings. In August 2023, Merck announced advancements in their viscoelastic formulations to enhance surgical efficiencies. There's a heightened focus on improving surgical outcomes and patient experiences through innovative designs and formulations that many companies, including Bausch Health Companies and Carl Zeiss, are pursuing.
Significant market growth has been reported due to the increasing number of cataract surgeries, with forecasts showing an increase in the market valuation of over 5% annually through 2027. In terms of mergers and acquisitions, Eyevance Pharmaceuticals acquired Oculentis in September 2023, aiming to expand their portfolio in ocular surgery solutions. The market has also witnessed Bausch Health Companies enhancing its product pipeline, which positively impacts market competitiveness and innovation.
Overall, ongoing Research and Development and strategic partnerships among these companies are driving advancements in the Ophthalmic Viscoelastic Devices Market in the US, aligning with the growing demand for improved ophthalmic surgical outcomes.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 700.7(USD Million) |
| MARKET SIZE 2024 | 752.15(USD Million) |
| MARKET SIZE 2035 | 1429.82(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.014% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Genentech, Santen Pharmaceutical, Eyevance Pharmaceuticals, Merck, Kessel Medical, Bausch Health Companies, Abbott Laboratories, Carl Zeiss, Hoya Corporation, AptarGroup, Alcon, SIFI, Johnson and Johnson, Medennium, Oculentis |
| SEGMENTS COVERED | Type, Application, End User |
| KEY MARKET OPPORTUNITIES | Aging population increasing cataract surgeries, Technological advancements in device formulation, Rising demand for minimally invasive procedures, Growth in ophthalmic surgery reimbursement policies, Expansion of ophthalmic research and clinical trials |
| KEY MARKET DYNAMICS | Growing geriatric population, Increasing eye surgeries, Technological advancements in devices, Rising prevalence of eye disorders, Expanding healthcare expenditure |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The projected market size of the US Ophthalmic Viscoelastic Devices Market in 2024 is 752.15 USD Million.
The expected market size of the US Ophthalmic Viscoelastic Devices Market by 2035 is 1429.82 USD Million.
The expected CAGR for the US Ophthalmic Viscoelastic Devices Market from 2025 to 2035 is 6.014%.
By 2035, the Cohesive OVDs segment is projected to dominate the market, valued at 850.0 USD Million.
The Dispersive OVDs segment is expected to be valued at 302.15 USD Million in 2024.
Major players in the US Ophthalmic Viscoelastic Devices Market include Genentech, Santen Pharmaceutical, Eyevance Pharmaceuticals, and Alcon.
The Cohesive OVDs segment is expected to grow from 450.0 USD Million in 2024 to 850.0 USD Million in 2035.
Key applications include cataract surgeries and other ophthalmic procedures which are driving significant growth in the market.
Challenges include regulatory hurdles and the high cost of advanced devices affecting market expansion.
Opportunities for new entrants include innovative product development and collaborations with medical institutions to enhance market reach.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
